3rd CML-CAB: Frankfurt, Germany, 29-30 May 2017


On 29-30 February 2017, the CML Community Advisory Board (CML-CAB), a workgroup of the CML Advocates Network, has hosted its third meeting to discuss issues of major concern to the CML community.

CML-CAB Members attending the 3rd CML-CAB as patient experts


The CML Advocates Network was represented by expert patient advocates from all world regions:


  • Jan Geissler, Germany (Co-chair)
  • Giora Sharf, Israel (Co-chair)
  • Jana Pelouchova, Czech Republic 
  • Mercedes Arteaga, Argentina (representing Latin America)
  • Pat Garcia-Gonzalez (representing Latin America)
  • Gail Sperling, USA (representing North America)
  • Bahija Gouimi, Morocco (representing Africa and the Middle East)
  • Rita Christensen, Denmark (representing Western Europe)
  • Rod Padua, Philippines (representing East Asia and Pacific)
  • Felice Bombaci, Italy (Western Europe)
  • Yair Bar David (representing Israel)
  • Ferdinand Micho, Kenya (Africa)
  • Silvia Castillo De Armas, Guatemala (Latin America)
  • Sarunas Narbutas, Lithuania (Eastern Europe)
  • Lisa Machado, Canada (representing North America)
  • Cornelia Borowczak, Germany

Plus the CML Advocates Network team Lidija Pecova and Celia Marín.


The following topics were discussed during the CML-CAB:

The following topics were discussed during the CML-CAB:

  • Pediatric CML 
  • Overview of TFR studies with Dasatinib
  • Guidelines on side effect management
  • Real-world data
  • Discussion: On collaboration between the patient community and BMS 

Non-confidential minutes of the meeting are available to CML Advocates Network members here. Please log in on the website with your membership account, and then download the file HERE. Downloads are not available for non-members.


EU e-Privacy Directive